CDNA Feb 2023 22.500 call
| Previous Close | 5.30 |
| Open | N/A |
| Bid | 3.30 |
| Ask | 7.80 |
| Strike | 22.50 |
| Expire Date | 2023-02-17 |
| Day's Range | 5.30 - 5.30 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
- Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Let's not try to jinx things by calling attention to this, but Cathie Wood's on a roll this year. The largest of the exchange-traded funds she runs at Ark Investment Management is up nearly 23% this month. Wood added to her existing stakes in Pinterest (NYSE: PINS), CareDx (NASDAQ: CDNA), and Teladoc Health (NYSE: TDOC) yesterday.
- Simply Wall St.
CareDx (NASDAQ:CDNA) delivers shareholders splendid 20% CAGR over 5 years, surging 9.8% in the last week alone
CareDx, Inc ( NASDAQ:CDNA ) shareholders might be concerned after seeing the share price drop 24% in the last quarter...
- Business Wire
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
BRISBANE, Calif., January 26, 2023--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Journal of the American College of Cardiology (JACC): Heart Failure has published a detailed guide1 to help clinicians transition from routine invasive endomyocardial biopsy (EMB) to a less invasive acute rejection monito
